Lixivaptan
CAS No. 168079-32-1
Lixivaptan( VPA-985 | WAY-VPA 985 )
Catalog No. M20804 CAS No. 168079-32-1
Lixivaptan is an orally active and selective vasopressin receptor V2 antagonist(Ki = 2.3 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 47 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 236 | In Stock |
|
| 50MG | 401 | In Stock |
|
| 100MG | 591 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLixivaptan
-
NoteResearch use only, not for human use.
-
Brief DescriptionLixivaptan is an orally active and selective vasopressin receptor V2 antagonist(Ki = 2.3 nM).
-
DescriptionLixivaptan is an orally active and selective vasopressin receptor V2 antagonist(Ki = 2.3 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsVPA-985 | WAY-VPA 985
-
PathwayGPCR/G Protein
-
TargetVasopressin Receptor
-
RecptorVasopressin Receptor
-
Research AreaMetabolic Disease
-
IndicationAutosomal dominant polycystic kidney disease
Chemical Information
-
CAS Number168079-32-1
-
Formula Weight473.93
-
Molecular FormulaC27H21ClFN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:150 mg/mL (316.50 mM)
-
SMILESCc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1
-
Chemical NameN-(3-chloro-4-(1011-dihydro-6H-benzo[e]pyrrolo[12-a][14]diazepine-5-carbonyl)phenyl)-5-fluoro-2-methylbenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang X Constans MM Chebib FT.et al.Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model[J].Am J Nephrol. 2019;49(6):487-493.
molnova catalog
related products
-
Terlipressin Acetate
Terlipressin, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R)-induced damage in intestinal epithelial cells (IEC-6).
-
E-4177
E-4177 is an angiotensin II type 1 receptor (AT1R) antagonist and can be used to study cardiovascular diseases.
-
OPC-51803
OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
Cart
sales@molnova.com